XML 66 R34.htm IDEA: XBRL DOCUMENT v3.8.0.1
DEBT (Details Narrative) - USD ($)
1 Months Ended 3 Months Ended 12 Months Ended
May 12, 2017
May 05, 2017
Apr. 10, 2017
Mar. 16, 2017
Aug. 04, 2016
Mar. 16, 2018
Feb. 19, 2018
Jan. 18, 2018
May 16, 2017
Mar. 23, 2017
Mar. 20, 2017
Nov. 16, 2015
Mar. 31, 2018
Dec. 31, 2017
Nov. 16, 2017
Jul. 31, 2017
Jan. 31, 2017
Dec. 31, 2016
Nov. 30, 2016
Oct. 31, 2016
Sep. 30, 2016
Sep. 13, 2016
Debt outstanding amount                         $ 3,078,442                  
Accrued interest                         266,661                  
Debt discount                         3,216,000 $ 3,350,000                
Amortization of debt discount             $ 392,272           836,484 360,890                
SkyPharm [Member]                                            
Short term debt borrowing capacity                         6,728,606                  
SkyPharm [Member] | MediHelm S.A. [Member]                                            
Amortization of debt discount                         36,066 69,269                
Monthly fees                         $ 349,485                  
Origination fees                           128,545                
SkyPharm [Member] | Trade Facility Agreements [Member]                                            
Description for the repayment The total facility will be calculated as 95% of the agreed upon value of Decahedrons receivables.                                          
Term of credit facility 12 months                                          
Credit facility origination fee, percentage 2.00%                                          
Monthly credit fee, percentage 1.00%                                          
Additional gain on settlement of debt $ 332,640                                          
Maximum aggregate amount supplement deed                 $ 18,480,000                          
SkyPharm [Member] | Trade Facility Agreements [Member] | Minimum [Member]                                            
Short term debt borrowing capacity                             $ 2,464,000              
SkyPharm [Member] | Trade Facility Agreements [Member] | Maximum [Member]                                            
Short term debt borrowing capacity                             $ 7,392,000              
On April 18, 2018 [Member]                                            
Maturity date                         Dec. 31, 2021                  
Libor rate description                        

Additionally, the interest rate was amended such that the interest rate for all advances is 4% plus the 3-Month Libor rate.

                 
Gain on debt settlement                         $ 24,287                  
Loan Facility July 6, 2017 [Member]                                            
Fees forgiven related to advance                         40,000                  
Loan facility agreement [Member]                                            
Debt discount                         191,034                  
Amortization of debt discount                         19,190                  
Unamortized debt discount                         24,932                  
Total amortized                         114,158                  
Loan facility agreement [Member] | SkyPharm [Member]                                            
Short term debt borrowing capacity         $ 1,292,769                                  
Interest rate         10.00%                                  
Description for the repayment        

The amounts owed under the Loan Facility shall be repayable upon the earlier of (i) three months following the demand of the lender; or (ii) August 31, 2018. No prepayment is permitted pursuant to the terms of the Loan Facility

                                 
Loan facility agreement [Member] | Grigorios Siokas [Member] | Synthesis facility agreement [Member]                                            
Common stock shares reserved         10,000,000                                  
Second amendment to loan facility agreement [Member] | SkyPharm [Member]                                            
Short term debt borrowing capacity                   $ 2,664,960       70,000   $ 382,327 $ 155,516 $ 452,471 $ 250,000 $ 100,000 $ 174,000  
Interest rate                   10.00%                        
Maturity date                   Aug. 04, 2016                        
Description for the repayment                  

The amounts owed under the A&R Loan Facility shall be repayable upon the earlier of (i) seventy five days following the demand of the Lender; or (ii) August 31, 2018.

                       
Common stock shares reserved                   1,000,000                        
Amendment to loan facility agreement [Member] | SkyPharm [Member]                                            
Short term debt borrowing capacity                                           $ 1,533,020
Debt outstanding amount                                           $ 240,251
Loan Agreement 2 [Member]                                            
Short term debt borrowing capacity           $ 1,848,000                                
Interest rate           4.70%                                
Maturity date           Mar. 18, 2019                                
Debt outstanding amount                         1,848,000                  
Accrued interest                         3,094                  
Loan Agreement 1 [Member]                                            
Short term debt borrowing capacity               $ 92,400                            
Interest rate               6.50%                            
Maturity date               Jan. 17, 2019                            
Loan Agreement 1 [Member] | Grigorios Siokas [Member]                                            
Debt outstanding amount                         92,400                  
Accrued interest                         1,201                  
Loan Agreement [Member] | Panagiotis Drakopoulos [Member]                                            
Short term debt borrowing capacity                       $ 43,624                    
Interest rate                       6.00%                    
Maturity date                       Nov. 15, 2016                    
Debt outstanding amount                         27,651 20,437                
Accrued interest                         2,463 $ 2,477                
Bridge Loans [Member] | SkyPharm [Member]                                            
Short term debt borrowing capacity   $ 34,745   $ 50,000             $ 120,220                      
Interest rate   10.00%   10.00%             10.00%                      
Maturity date   Sep. 30, 2017   Apr. 16, 2017             Apr. 20, 2017                      
Amended maturity date       May 16, 2017             May 20, 2017                      
Debt outstanding amount       $ 50,000             $ 106,542   34,745                  
Accrued interest       $ 11,448             11,448   $ 2,802                  
Gain on debt settlement                     20,482                      
Additional gain on settlement of debt                     4,854                      
Loan fixed payoff amount                     $ 106,542                      
Decahedron [Member] | SkyPharm [Member] | Trade Facility Agreements [Member]                                            
Short term debt borrowing capacity     $ 3,388,000                                      
Description for the repayment     The total facility will be calculated as 95% of the agreed upon value of Decahedrons receivables                                      
Term of credit facility     12 months                                      
Credit facility origination fee, percentage     2.00%                                      
Monthly credit fee, percentage     1.00%